EBO.NZ · NZE · Healthcare
EBOS Group Limited
Also onConsensus Drift
Implied value per share
NZD 50.87
Market price
NZD 19.84
Implied upside
+156.4%
5-year forecast · Perpetuity growth terminal value · Mid-year discounting · Base case · AUD model at 1.2435
Value Per Share
Same forecast, different terminal treatment. Percentages vs price.
Forecast Cashflows
Reporting currency (AUD). Outflows negative.
| Line | FY27 | FY28 | FY29 | FY30 | FY31 | CAGR |
|---|---|---|---|---|---|---|
| Revenue | AUD 17.6bn | AUD 18.9bn | AUD 20.2bn | AUD 21.7bn | AUD 23.2bn | +7.2% |
| EBIT | AUD 600.3m | AUD 643.5m | AUD 689.9m | AUD 739.6m | AUD 792.8m | +7.2% |
| NOPAT | AUD 432.2m | AUD 463.3m | AUD 496.7m | AUD 532.5m | AUD 570.8m | +7.2% |
| Add depreciation & amortisation | AUD 199.2m | AUD 213.5m | AUD 228.9m | AUD 245.4m | AUD 263.1m | +7.2% |
| Less capital expenditure | AUD -199.2m | AUD -213.5m | AUD -228.9m | AUD -245.4m | AUD -263.1m | +7.2% |
| Less increase in working capital | AUD -71.8m | AUD -77.0m | AUD -82.6m | AUD -88.5m | AUD -94.9m | +7.2% |
| Free cashflow to firm | AUD 360.4m | AUD 386.3m | AUD 414.2m | AUD 444.0m | AUD 476.0m | +7.2% |
| Discount factor | 0.9705 | 0.9141 | 0.8610 | 0.8110 | 0.7639 | - |
| Present value | AUD 349.8m | AUD 353.2m | AUD 356.6m | AUD 360.1m | AUD 363.6m | +1.0% |
| Present Value Of The Forecast | AUD 1.8bn | |||||
Discount Rate
Source shown per component. All overridable above.
| Risk-free rate | 4.50% | NZD assumption - no free live source available for this market (assumption) |
| Equity risk premium | 6.50% | Market assumption |
| Beta | 0.428 | Reported 0.146, pulled toward 1.0 (Blume) |
| Cost of equity | 7.28% | Risk-free + beta x equity risk premium |
| Cost of debt | 5.81% | Interest expense / average total debt |
| Market capitalisation | AUD 4.1bn | 64.0% of capital |
| Total debt | AUD 2.3bn | 36.0% of capital, book value as a proxy |
| Tax rate | 28.0% | Effective, capped at statutory |
| WACC | 6.17% | E/V x Re + D/V x Rd x (1 - t) |
Terminal Value
Perpetuity growth is intrinsic. The exit multiple defaults to the company's current EV/EBITDA, so it answers a different question - what the shares are worth if today's rating holds and EBITDA grows as forecast.
Perpetuity growth at 2.50%
83% of EV
- Forecast FCFF, final year
- AUD 476.0m
- Capex at depreciation, working capital in reinvestment
- AUD 570.8m
- Less reinvestment at g/ROIC (28.8% of NOPAT)
- AUD -164.5m
- Capitalised
- AUD 406.4m
- ROIC (reported)
- 8.7%
- Terminal value, undiscounted
- AUD 11.4bn
- Terminal value, discounted
- AUD 8.7bn
- Enterprise value
- AUD 10.5bn
- Less net debt
- AUD 2.0bn
- Equity value
- AUD 8.4bn
Exit at 9.0x EBITDA
80% of EV
- Terminal value, undiscounted
- AUD 9.5bn
- Terminal value, discounted
- AUD 7.3bn
- Enterprise value
- AUD 9.1bn
- Less net debt
- AUD 2.0bn
- Equity value
- AUD 7.1bn
Spread between methods: 18%.
Sensitivity
Value per share (AUD) by discount rate and long-run growth.
| Long-run growth | |||||
|---|---|---|---|---|---|
| Discount rate | 1.50% | 2.00% | 2.50% | 3.00% | 3.50% |
| 4.17% | 71.73 | 82.64 | 100.00 | 132.13 | 212.17 |
| 5.17% | 49.55 | 53.71 | 59.39 | 67.62 | 80.72 |
| 6.17% | 36.88 | 38.66 | 40.91 | 43.82 | 47.78 |
| 7.17% | 28.68 | 29.44 | 30.34 | 31.42 | 32.77 |
| 8.17% | 22.94 | 23.20 | 23.49 | 23.81 | 24.18 |
Outlined: this model. Green text: above today's price of 15.95. Shading: distance from this model's own value.
Priced In
What each input would have to be to justify the current price, one at a time.
| Input | Model | Implied | Gap |
|---|---|---|---|
| Revenue growth, every year | 7.2% | -9.8% | -17.0pp |
| EBIT margin | 3.4% | 1.8% | -1.6pp |
| Discount rate | 6.2% | 10.2% | +4.1pp |
Live formulas, not pasted numbers - edit a driver and the workbook reprices.
Yahoo Finance and RBA data. General information, not advice. Methodology.